It would be hard to miss the sudden explosion of activity around insulin pricing and access in 2019. JDRF and ADA are hard at work; bills are being developed and measured at the State and Federal levels, and the Big 3 (Eli Lilly, Sanofi and Novo Nordisk) are facing lawsuits for collusion on insulin pricing. 2019 is our year! Ok... this is all well and good, but what can we personally do about it?
Please join us for a drink and informal discussion with Denver-based Christine Fallabel (Director, American Diabetes Association State Government Affairs and Advocacy), AJ McCulloch (Territory Operations Manager, American Diabetes Association Youth and Family Initiatives), and State Reps Dylan Roberts and Lisa Cutter on these topics and likely much more.